Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05594693 · ClinicalTrials.gov registry record
Integrative Health Interventions in Symptom Management of Pediatric Patients
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 100
- Enrollment target
NCT05594693: Completed study, sponsored by University of Colorado, Denver.
NCT05594693 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05594693 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
As healthcare demands high-quality cost-effective care and patients seek self-management strategies, integrative medicine has become more of an interest to patients, physicians, and administrators. The NIH has a dedicated center (National Center for Complementary and Integrative Health) for integrative therapies. Additionally, these treatments must meet evidence-based criteria for efficacy to be considered for reimbursement and in order for clinical settings to integrate them into the standard of care.
Primary Outcome
The team will determine which therapy will be used when administering the questionnaire
Interventions
- OTHER Questionnaire
- OTHER Physical Exam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-06-16 |
| Est. Completion | 2024-02-26 |
What the finished NCT05594693 record still lists
NCT05594693 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire is the first listed.
NCT05594693 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05594693 about?
NCT05594693 is a clinical study titled "Integrative Health Interventions in Symptom Management of Pediatric Patients". As healthcare demands high-quality cost-effective care and patients seek self-management strategies, integrative medicine has become more of an interest to patients, physicians, and administrators. The NIH has a dedicated center (National Center for Complementary and Integrative Health) for integrat...
What is the current status of trial NCT05594693?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2022-06-16. Estimated completion is 2024-02-26.
What interventions are being tested in trial NCT05594693?
The interventions under investigation include: Questionnaire (OTHER), Physical Exam (OTHER).
Who is sponsoring clinical trial NCT05594693?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI